COMMUNIQUÉS West-GlobeNewswire

Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social

04/02/2025 - 22:30

(Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) PARIS, 04 févr. 2025 (GLOBE NEWSWIRE) -- Place de cotation : Euronext Growth ISIN code: FR0010425595 Date Nombre total d’actions composant le [...]

Conavi Medical Retains BND Projects Inc. for Corporate Development Services

04/02/2025 - 22:30

TORONTO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (“ Conavi ” or the “ Corporation ”), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging [...]

Monthly information on share capital and company voting rights

04/02/2025 - 22:30

(Article 223-16 of General Regulation of the French financial markets authority) PARIS, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Listing market: Euronext Growth ISIN code: FR0010425595 Date Total number of shares in the [...]

Jasper Therapeutics to Present at the Oppenheimer Healthcare Life Sciences Conference

04/02/2025 - 22:30

REDWOOD CITY, Calif., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a clinical stage biotechnology company focused on development of briquilimab, a novel antibody therapy targeting [...]

Annovis Bio, Inc. Announces Closing of $21 Million Public Offering

04/02/2025 - 22:31

MALVERN, PA, Feb. 04, 2025 (GLOBE NEWSWIRE) -- via IBN - Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative [...]

Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine

03/02/2025 - 14:30

Funding will Support Ongoing RIDGE™ -1 Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy Initial Data from RIDGE-1 Phase 1b Clinical [...]

Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study

03/02/2025 - 14:30

HOUSTON, TX, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, announces the [...]

Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation

03/02/2025 - 14:30

Dallas, TX & Quebec, Canada, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of men’s wellness products and services via a [...]

Safety Shot, Inc. Terminates At-the-Market Equity Offering, Reaffirms Strong Financial Position and Growth Trajectory

03/02/2025 - 14:30

SCOTTSDALE, Ariz., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or the "Company"), a leading wellness and dietary supplement company, today announced the termination of its at-the- [...]

MedBright AI Appointments Brandon Kou as Director

03/02/2025 - 14:30

VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “ Company ” or “ MedBright AI ”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) is pleased to announce that Brandon Kou has joined [...]

Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location

03/02/2025 - 14:30

WINTER PARK, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), through its medical division Adia Med, is strategically positioning itself to capture a significant share of the growing $15.1 [...]

Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™

03/02/2025 - 14:45

Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety of tissues and organs, including the CNS TOKYO, LONDON and BOSTON, Feb. 03, [...]

Procaps Group Receives Delisting Notice From Nasdaq

03/02/2025 - 14:50

MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today [...]

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025

03/02/2025 - 15:00

SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]

PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service

03/02/2025 - 15:05

MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company’s [...]

King Faisal Specialist Hospital & Research Centre Ranks 15th Globally

03/02/2025 - 15:20

Maintaining its Leadership in the Middle East and North Africa RIYADH, Saudi Arabia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- In an unprecedented achievement reflecting its excellence in specialized healthcare and medical [...]

BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors

03/02/2025 - 15:25

Frissora is recognized for his ability to lead organizations through complex challenges and deliver sustained value creation LAS VEGAS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), a pioneering [...]

Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens et Bayshore HealthCare s’unissent pour appuyer les vétérans et les Jeux Invictus Vancouver Whistler 2025

03/02/2025 - 15:30

HAMILTON, Ontario, 03 févr. 2025 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens (CESLDC) est heureux d’annoncer sa présence aux Jeux Invictus Vancouver Whistler 2025 [...]

Chronic Pain Centre of Excellence for Canadian Veterans and Bayshore HealthCare Unite to Support Veterans at Invictus Games Vancouver Whistler 2025

03/02/2025 - 15:30

HAMILTON, Ontario, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans (CPCoE) is excited to announce its attendance at the Invictus Games Vancouver Whistler 2025 presented by [...]